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SUMMARY
Eleven cases of poliomyelitis, 8 paralytic, have been reported to the Commu­
nicable Disease Center through the 20th week of 1965. This represents one-third the 
total number of cases reported during the corresponding period of 1964, the previous 
record low year. The only areas where more than one case have been reported are 
Morrill County, Nebraska and Pinal County, Arizona. Summaries of the Nebraska and 
Arizona outbreaks are presented in Section II.
The final report of 1964 paralytic cases reported to the PSU is presented in 
Section III. Sixty-day follow-up reports were received on 100 percent of the pre­
liminary PSU forms. For 1964, the "Best Available Paralytic Case Count" was 91 para­
lytic cases. This total is less than one-third that recorded in 1963, previously the 
record low year. Of the 91 paralytic cases, only 12,5 percent were considered ade­
quately immunized with inactivated polio vaccine (4 or more doses) and only 8.8 per­
cent were fully immunized with oral poliomyelitis vaccine. Nineteen of the 91 para­
lytic cases occurred within 30 days following administration of oral poliomyelitis 
vaccine. There was no seasonal rise in incidence during the summer months and no 
epidemics were noted. There were 51 isolations of poliovirus from the 91 paralytic 
cases in 1964. Type III accounted for 47 percent of the total and Type I accounted 
for 41 percent.
An analysis of the poliomyelitis vaccination status in the United States as 
determined by the national immunization survey conducted annually since 1957 is 
presented in Section IV. While the percentage of persons receiving 3 or more doses 
of inactivated poliomyelitis vaccine has remained comparable to previous years, the 
increased utilization of oral poliomyelitis vaccine since 1962 has accounted for a 
general increase in the percentage of the population considered adequately immunized.
A review of poliomyelitis in Jamaica, including the epidemic of 1964-65, is 
presented in Section V.
The supplement to this report contains the results of the 1964 national immu­
nization survey conducted by the Bureau of the Census in cooperation with the Commu­
nicable Disease Center. These results include the data regarding immunization status 
of the population against poliomyelitis, diphtheria-pertussis-tetanus, smallpox and 
influenza.
I. CURRENT POLIOMYELITIS MORBIDITY TRENDS
Through the 20th week of 1965 a total of 11 cases of poliomyelitis, 8 of which 
are paralytic, have been reported. This total compares to the 26 cases reported 
through the 20th week of 1964 and is 10 percent of the median number of cases reported 
for a similar period during the years 1960-64.
If present trends continue and no large outbreaks occur, 1965 may again be a 
record low year. Thus far, no cases of poliomyelitis have been reported to have 
occurred within 30 days of either oral or inactivated vaccine.
The only 2 counties which have reported more than a single case in 1965 are 
Morrill County, Nebraska where 2 paralytic cases have been recorded and Pinal County, 
Arizona where 4 cases, of which 2 were paralytic, (one with December 1964 onset) were 
recorded over a 4 month period. Special reports on the Nebraska and Arizona cases 
are presented in Section II. In addition, during the first 20 weeks of 1965 3 cases 
have been reported from 3 different counties in Texas and single cases have been re­
ported from Minnesota, New Mexico, and California.
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II. STATE REPORTS
Arizona
During a 4 month period beginning in December 1964, 4 cases of poliomyelitis 
including 2 paralytic cases were reported from Pinal County (population 62,673). A 
line listing of the cases appears below:
Vacc. Status
Case Age Race Sex Onset
Para.
Status
No.
IPV
Doses
OPV
Virus
Isol.
1 2 W F 12/27/64 P 0 0 No spec.
2 1 5/12 W F 2/19/65 P 0 0 Type I •
3 2 1/2 W F 3/29/65 NP 0 0 Neg.
4 38 W F 4/1/65 NP 0 3 Type I
The initial case, a 2 year old girl, became ill on December 27, 1964, with
fever, anorexia and irritability. She subsequently had paralytic involvement with 
residual weakness of the right leg. The subsequent cases developed illness between 
February 19, 1965 and April 1, 1965. One of the 2 non-paralytic cases was in a 38 
year old female who was the only one who had received any vaccine. She had received 
a full course of oral poliomyelitis vaccine in 1962, The other 3 cases were all un­
immunized preschool age children. All cases occurred in white females who resided in 
lower socioeconomic areas. The cases were not geographically clustered within Pinal 
County.
In 1962 a county wide mass immunization program utilizing monovalent oral polio­
myelitis vaccines had been conducted. In addition, inactivated poliomyelitis vaccine 
was available to the population on a continuing basis through regular poliomyelitis 
immunization clinics conducted by the County Health Department. A health index survey 
was conducted by the Communicable Disease Center in the fall of 1964 in Casa Grande 
(population 8,311), the largest community in Pinal County. Among children from upper 
socioeconomic areas, 76.3 percent had received either 3 or more doses of inactivated 
poliomyelitis vaccine or 3 doses of oral poliomyelitis vaccine, or both. Only 22 per­
cent of children in the lower socioeconomic area had achieved the same level of immu­
nization. It was primarily among this group of unimmunized children from the lower 
socioeconomic areas that the current outbreak occurred.
During the first week in April, a county wide vaccination program utilizing 
Type I oral poliomyelitis vaccine from the CDC epidemic reserve was administered by 
the State and County Health Departments. Since the vaccination program, no additional 
cases have been reported.
Nebraska
Two cases of paralytic poliomyelitis including one 
County, Nebraska. A line listing of the cases appears on
death have occurred in Morrill 
the following page:
2
Case Location Age Race Sex
1 Morrill Co. 11 Sp. Am. F
2 Morrill Co. 11 mo. Sp. Am. M
Onset
Para.
Status
Vacc.
No.
IPV
Status
Doses
OPV
Virus
Isol.
5/9/65 Died
5/13/65
1 0 ft
5/12/65 P 0 0 Type
* Poliovirus Type I has been recovered from the stools of 7 of 8 siblings studied.
The first case, an 11 year old girl, became ill on May 9, 1965, 5 days after 
returning from a visit to El Centro, California. Initial symptoms of fever and nausea 
were followed by stiff neck and flaccid paralysis of both lower extremities which 
progressed rapidly to include the upper extremities and respiratory musculature. The 
patient died on May 13. The second case is an 11 month old male cousin of the first 
case and had onset of illness on May 12. This patient has weakness of the left arm 
and left facial nerve. Neither case had been adequately immunized against poliomyelitis.
Stool specimens from 7 of 8 siblings of the first case have yielded Type I polio­
virus at the Virology Laboratory, Department of Microbiology, University of Nebraska, 
and confirmed as Type I at the CDC Kansas City Field Station. Laboratory studies on 
specimens from the second case are in process.
A mass vaccination program utilizing Type I oral poliomyelitis vaccine from the 
CDC epidemic reserve, was conducted by the Nebraska Department of Health, in Morrill 
County (population 7,000) and adjacent Scotts Bluff County (population 34,000) on June 
6.
(Reported by Dr. E. A. Rogers, Director of Health, Nebraska Department of Health.)
Ill. 1964 POLIOMYELITIS REPORTED TO PSU - FINAL REPORT
During 1964, the Poliomyelitis Surveillance Unit received individual surveillance 
case records on 115 cases of poliomyelitis. Follow-up reports, 60 days or longer after 
onset of illness, were received on all 115 of these cases. The diligent and persistent 
efforts of State and local health officials, particularly the State Epidemiologists, 
have made this completeness of follow-up possible.
Individual surveillance case records, consisting of a preliminary and 60-day 
follow-up report have been submitted to the Poliomyelitis Surveillance Unit since 1958. 
Follow-up reports have been received on over 90 percent of the preliminary forms for 
the past 5 years as shown in the table below:
Table I
Poliomyelitis Surveillance Unit
Total Poliomyelitis 
No. States Cases Reported
Case Records 
60-Day 60-Day
Year Participating To MMWR Preliminary Follow-ups Follow-'
1958 49 5,787 6,125 4,919 80.3
1959 50 8,425 8,635 7,523 87.1
1960 51 3,190 3,304 3,095 93.7
1961 51 1,312 1,356 1,284 94.7
1962 51 910 914 898 98.2
1963 51 449 437 425 97.3
1964 51 121 (Preliminary) 115 115 100.0
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Since 1958, the best continuing index of paralytic disease due to poliomyelitis 
has been those cases with residual paralysis at 60 days and cases reported initially 
as paralytic but with no 60-day follow-up report. The total thus obtained represents 
the "Best Available Paralytic Poliomyelitis Count." The 103 cases initially reported 
to the PSU as paralytic poliomyelitis in 1964 are shown in Table II by final classi­
fication. The "Best Available Paralytic Poliomyelitis Count" for 1964 includes the 
91 cases with residual paralysis.
Table II
Final Classification of 103 Cases Initially 
Reported as Paralytic Poliomyelitis, United States, 1964
Final Classification Paralytic
Paralytic
residual
Polio with 
paralysis 91
Paralytic
residual
Polio - no 
paralysis 11
Paralytic 
to other
Disease due 
agent - unspecified 1
TOTAL 103
In 1964, the number of reported cases of paralytic poliomyelitis in the United 
States reached a record low level. The final case count of 91 paralytic cases for 
1964 is less than one-third the total reported in 1963, the previous record low year.
No county reported more than 2 cases during any month of 1964. Cases occurring within 
30 days of receiving oral poliomyelitis vaccine accounted for 19 of the total of 91 
paralytic cases. A line listing of these cases appears on page 8.
Unlike previous years when an increased incidence occurred during the summer 
and fall months, the seasonal distribution of the cases was relatively uniform. (See 
Figure 1) All of the 19 cases occurring within 30 days of oral poliomyelitis vaccine 
administration became ill during the first 6 months of the year. This coincides with 
the monthly distribution of monovalent oral poliomyelitis vaccine distribution in the 
United States as shown in Figure 2.
The 91 paralytic cases are shown by age and inactivated poliomyelitis vaccine 
status in Table III. There were 38 cases (42 percent) in the 0-4 year age group and 
23 (25 percent) in the 5-14 year age group. In the 15 year and older age group there 
were 30 cases of which 15 occurred within 30 days after the administration of oral 
poliomyelitis vaccine. As in previous years, the majority of the 91 cases had no 
previous immunization with inactivated poliomyelitis vaccine. Two-thirds of the total 
had never received any inactivated poliomyelitis vaccine and only 12.5 percent had 
received 4 or more doses of inactivated poliomyelitis vaccine.
The 91 paralytic cases are shown by age and oral poliomyelitis vaccine status 
in Table IV. Excluding those cases which occurred within 30 days following adminis­
tration of oral poliomyelitis vaccine, a total of 8 cases occurred among individuals 
who had previously received a full series of oral poliomyelitis vaccine (3 doses of 
monovalent oral poliomyelitis vaccine or 2 doses of trivalent oral poliomyelitis 
vaccine). A line listing of these cases appears on page 9. The 8 cases were all
less than 15 years of age and 6 had received 3 or more doses of inactivated poliomyelitis
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Table III
Paralytic Poliomyelitis by Age Group 
And Inactivated Vaccination History 
United States, 1964
Age _____Doses of Inactivated Vaccine Total
Group OV IV 2V 3V 4+V Unk. Cases Percent Deaths
0-4 28 1 3 4 1 1 38 41.8 3
5-9 7 1 1 1 5 1 16 17.6 1
10-14 2 0 0 2 3 0 7 7.7 1
15-19 6 0 0 1 1 0 8 8.8 0
20-29 2 1 1 0 0 0 4 4.4 0
30-39 5 0 2 0 0 0 7 7.7 0
40+ _8 _£ _0 _1 _1 _1 11 12.1 _2
TOTAL 58 3 7 9 11 3 91 100.0 7
Percent
Doses 65.9 3.4 8.0 10.2 12.5 100.0
Table IV
Paralytic Poliomyelitis by Age Group 
And Oral Vaccination Status 
United States, 1964*
Doses of Oral Vaccine
Age Monovalent Trivalent Total
Group Unvaccinated 1 type only 2 types 3 types 1 dose 2 doses Cases
0-4 29 4 (1) 1 (1) 2 2 (1) 0 38
5-9 9 1 2 (1) 2 2 0 16
10-14 3 0 0 4 0 0 7
15-19 4 3 (3) 0 1 (1) 0 0 8
20-29 3 1 (1) 0 0 0 0 4
30-39 4 0 2 (2) 0 1 (1) 0 7
40+ 4 1 (1) 1 (1) 2 (2) 3 (3) 0 11
TOTAL 56 10 (6) 6 (5) 11 (3) 8 (5) 0 91 (19)
* <30 day cases are shown in parenthesis.
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vaccine. Several cases showed poor antibody response to the poliomyelitis antigens as 
measured by complement fixation tests. From the 6 cases in which virus isolation was 
attempted, 2 poliovirus isolates, both Type I, were recovered.
Because of the small number of total cases, special efforts were made to obtain 
specimens for virus isolation and serologic study from all cases. Isolates were 
obtained from 51 of 77 fecal specimens examined for virus isolation. Of these, 24 
(47 percent) were Type III, 21 (41 percent) Type I, and 6 (12 percent) Type II (see 
Table V). This contrasts with the distribution of isolates obtained during the period 
1958 to 1963 during which Type I isolates accounted for 60 to 89 percent of the total 
each year and Type III varied from 10 to 38 percent. The proportional increase in Type 
III isolates reflects in part a relative increase in cases associated with the adminis­
tration of Type III vaccine and an absence of the usual Type I epidemics. The 1964 
poliovirus isolates are shown by State in Table VI.
Table V
Poliovirus Isolations
From Paralytic Cases, United States, 1958-64
Percent of
Numbers of Cases Percent Viruses Identified Total. Specified
Residual Specimens of Cases Type Type
Year Paralysis Submitted* Studied I II III Unk. I II III
1958 3301 1479 44.8 898 29 194 10 80.1 2.6 17.3
1959 5472 2775 50.7 1881 10 228 23 88.8 0.5 10.8
1960 2218 1072 48.3 603 1 219 2 73.3 0.1 26.6
1961 829 481 58.0 231 6 145 0 60.5 1.6 37.9
1962 691 472 68.3 300 8 100 0 73.5 2.0 24.5
1963 336 242 72.0 160 6 31 0 81.2 3.0 15.7
1964 91 77 84.6 21 6 24 0 41.2 11.8 47.0
^Includes all paralytic cases on which one or more fecal specimens were examined for 
virus isolation. State and local health department laboratories and laboratories in 
academic centers reported these results through State epidemiologists to the Polio­
myelitis Surveillance Unit.
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Table VI
Poliovirus Isolations 
by State - 1964
Total
Total Cases Poliovirus
Para. Lab Isolations
State Cases Studied I_ II_ III
Alabama 3 3 - - -
Arizona 2 0 - - -
Arkansas 1 0 - - -
California 3 2 - - 2
Colorado 1 0 “ -
Connecticut 1 1 1 - -
Florida 9 9 8 - -
Georgia 3 2 - -
Idaho 1 1 1 - -
Illinois 5 3 “ 2
Indiana 5 4 2 - -
Iowa 1 0 - - -
Kansas 1 1 - - 1
Louisiana 1 1 - - 1
Maine 1 1
Maryland 1 1 1 - -
Michigan 3 3 1 1 1
Minnesota 2 2 -
Mississippi 1 1 - 1 -
Missouri 2 2 — 1
Nebraska 1 1 - - -
New Hampshire 1 1 - - -
New Jersey 2 2 - “ -
New York 6 6 1 1 3
North Carolina 6 5 2 1 1
North Dakota 1 0 • • •
Ohio 2 2 - - 2
Oklahoma 2 2 - - 2
Oregon 1 1 - - -
South Carolina 1 1 — “
Tennessee 2 2 1 - 1
Texas 11 11 2 - 4
Virginia 3 3 - - 1
West Virginia 1 1 -
Wisconsin 2 1 - 1
Wyoming 2 1 1 “
TOTAL 91 77 21 6 24
States with no paralytic cases are not shown
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1964 Poliomyelitis with Residual Paralysis 
Occurring Within 30 Days after OPV
State County
Ala.
Ala.
*Colo.
*Fla.
Age Sex Onset
Escambia
Escambia
Prowers
Dade
18
28
15
4mos.
M
M
M
F
1-26
3- 28
4- 11 
4-29
Doses
IPV
0
0
0
0
Interval (Days) 
OPV to Onset
II
7mos. 6mos.
Ill Tri.
21
20
14
13
Virus
Isol.
Ill
III
60-Day
Status* *
Ga. Bartow 15 M 3-5 5 25 - - - Neg. 3
111. Adams 3mos. M 1-28 Unk. - - 11 - Ill 3
Md. Pr. Georges 15 M 5-9 0 20 - - - I 4
Maine Penobscot 41 M 3-14 Unk. 2yrs. 2yrs. 5 - - 3
N.J. Mercer 35 M 2-1 0 48 - 13 - Neg. 3
N.J. Morris 41 F 3-23 4 63 - 22 - Neg. 2
N.Y. Nassau 37 M 4-27 0 - - - 8 II 2
N.C. Alamance 43 M 3-16 0 - - - 15 I 5
N.C. Forsyth 43 M 3-9 0 - - - 8 II 4
N.C. Mecklenburg 48 M 4-7 0 - - - 16 III 3
N.C. Lenoir 49 M 6-14 0 84 28 56 - - 4
Ohio Lucas 8mos .• M 4-6 0 38 - 13 - Ill 3
*Tenn. Henderson 5 M 3-20 1 40 - 5 - I 2
*Va. Fairfax 59 F 5-6 0 11 - - - Neg. 3
*Wis. Dane 33 M 3-12 Unk. 60 - 18 - - 2
* Cases reported after Surgeon General's Committee meeting of July 17-18, 1964.
** Clinical Status at 60 Days:
2 - Minor involvement
3 - Significant disability
4 - Severely disabled
5 - Death
m cm cn
Paralytic Poliomyelitis Occurring in Persons Receiving Full 
Series of OPV - 1964 (Excluding <30 Day Cases)
State Age Sex
Onset
(1964)
IPV
Status
Arkansas 10 F 12-15 4
Florida 5 F 6-15 2
Georgia 3 M 9-20 3
Illinois 9 M 5-14 4
Nebraska 1 F 9-30 Unk.
New York 10 M 7-19 4
Oregon 14 F 4-14 3
Texas 14 M 9-2 3
OPV (month & yr. received)
I II III
Tri-
valent
Virus
Isol.
1-63 4-63 3-63 - -
1-64 4-64 2-64 - I
2-64 4-64 3-64 - Neg.
Date
Unk.
Date
Unk.
Date
Unk. - -
5-63 4-63 6-63 - Neg.
4-63 5-63 5-63 - I
9-62 9-62 7-62 - Neg.
1963 1963 1963 - Neg.
Serology* (CF-reciprocal) Residual
Date I II Ill Paralysis* **
3
6-19 1:4
7-21 1:64 - 2
9-24 16 <8 <8 3
10-2 <8 <8 <8
10-2 Neg. Neg. Neg. 3
10-13 Neg. Neg. Neg.
7-22 1:8** - - 4
8-27 1:64 - -
5
9-4 Neg. Neg. Neg. 3
10-1 Neg. Neg. Neg.
* - : No result received
Neg.: Lab report did not state titer; only that serology test was negative.
** Neutralization test
*** 2 - Minor involvement
3 - Significant disability
4 - Severely disabled
5 - Death
200
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140
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100
80
6 0
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20
0
Figure i
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IV. 196*+ NATIONAL IMMUNIZATION SURVEY - POLIOMYELITIS VACCINES
As in past years, the results of the annual United States immunization survey 
are presented as a supplement to the Poliomyelitis Surveillance Report. The immuniza­
tion status of the population has been studied annually since 1957 by means of a supple­
mental schedule included each September in the Current Population Survey conducted by 
the U.S. Bureau of the Census in cooperation with the Communicable Disease Center.*
During the years, 1957-1961, information was obtained on inactivated poliomyelitis 
vaccine (IPV) only. In 1962, coverage was extended to include oral poliomyelitis vaccine 
(OPV) and diphtheria-pertussis-tetanus immunization. In 1963 and 1964, questions con­
cerning influenza and smallpox vaccines were added to the survey questionnaire. The 1964 
survey findings are presented in the supplement to this report.
The poliomyelitis vaccination status of the U.S. population, as indicated in the 
supplement tables, reflects the widespread use of oral poliomyelitis vaccine since its 
licensure in the latter part of 1961. The following table shows the increase in the 
oral poliomyelitis vaccination level in all age groups between the years 1962, 1963 and 
1964. During this same period of time, the proportion of persons reporting 3 or more 
doses of inactivated poliomyelitis vaccine has remained essentially stable with some 
decrease in the youngest age groups.
National Immunization Survey Findings 
September 1962, 1963, and 1964 
Poliomyelitis Vaccination Status
Oral Poliovaccine Inactivated Poliovaccine
Age Percent Reporting 3 Doses Percent Reporting 3 or More Doses
Group 1962 1963 1964 1962 1963 1964
1-4 5.7 28.7 46.8 72.6 67.7 60.9
5-9 5.7 33.6 56.4 85.8 84.3 80.9
10-14 5.2 34.0 57.7 86.2 85.2 82.6
15-19 4.1 28.2 49.8 79.2 78.8 77.7
20-29 3.7 21.4 38.4 55.0 55.4 54.9
30-39 4.3 23.1 41.9 44.7 43.8 43.5
40-49 3.8 19.8 37.4 23.9 26.3 28.0
1-49 4.6 26.4 46.2 61.3 60.7 59.3
* Years Covered
1955-57:
1957-1961:1)
2)
1962:
1963:
1964:
Sirken, M.G. and Brenner, B.: Population characteristics and participation
in the poliomyelitis vaccination program. PHS Publication No. 723 (Public 
Health Monograph No. 61). U.S. Government Printing Office, Washington, D.C., 
1960.
Sirken, M.G.: National participation trends, 1955-61, in the poliomyelitis
vaccination program. Public Health Rep. 77:661-670, August 1962.
Morris, L.: Further analysis of national participation in the inactivated
poliomyelitis program, 1955-61, Public Health Rep. 79:469-480, June 1964.
Supplement to Poliomyelitis Surveillance Report No. 276, March 29, 1963.
Supplement to Poliomyelitis Surveillance Report No. 284, April 20, 1964.
Supplement to Poliomyelitis Surveillance Report No. 287, June 1, 1965.
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With two agents available, an estimate of the population with immunization 
against poliomyelitis would include not only those receiving a full series of inacti­
vated vaccine but also those who did not receive a full series of inactivated vaccine 
but did receive 3 doses of oral vaccine. This type of cross-classification is presented 
in the 1964 survey findings and appears for age groups 1-4 and 5-9 in Section D, Table 
16 of the supplement.
As shown in Section A of the supplement, 32.2 percent of the population from 1 
through 4 years of age have received 4 or more doses of inactivated poliomyelitis 
vaccine (IPV) and 60,9 percent have received 3 or more doses. The corresponding per­
centages for the 5 to 9 age group are 57,9 percent and 80.9 percent. Utilizing the 
findings of the 1964 survey, the proportion of children in these age groups protected 
by either inactivated or oral vaccine is shown in the following table:
Total Proportion Immunized 
With Full Series of IPV or Full Series of OPV 
Age Groups 1-4 and 5-9, Sept., 1964
Age Group
Percent Reporting 
4 or More 3 Doses of OPV
Doses of IPV and 4 Doses of IPV
Total Proportion 
Immunized
1-4 years 32.2 30.7
5-9 years 57.9 23.0
62.9
80.9
Age Group
Percent Reporting_______
3 or More 3 Doses of OPV
Doses of IPV and 3 Doses of IPV
Total Proportion 
Immunized
1-4 years 60.9 17.8 78.7
5-9 years 80.9 9.9 90.8
V. FOREIGN REPORT
POLIOMYELITIS IN JAMAICA
This report was prepared by Dr. Donald Luck, Senior Medical Officer,
Ministry of Health, Jamaica, and was presented by Dr. Luck at the Tenth 
Scientific Session of the Standing Advisory Committee for Medical Research 
for the British Caribbean, March 31, 1965, at Barbados, B.W.I.
Introduction
Poliomyelitis first appeared in epidemic form in Jamaica in 1954. Prior to that, 
the virus had been present on the Island, but clinical disease had been rare. The 
characteristics of succeeding epidemics have been somewhat modified by the effects of 
immunization against the disease. It is quite probable that prior to 1954 the bulk of 
the population had been naturally infected with the virus at an early age, thus confer­
ring widespread natural immunity upon the population. After the Second World War, in­
creasing standards of sanitation and hygiene undoubtedly protected many of the people 
on the Island from having contact with the virus at an early age, and thus a group of 
susceptibles was built up in the older age groups. Since the widespread use of polio 
vaccines, much of the population has become artificially immunized against the disease, 
and presumably natural spread of the virus has greatly decreased. It is interesting
13
that the most recent epidemic of polio in Jamaica was almost completely limited to 
children born since the last mass immunization campaign, thus indicating that newly 
born children may no longer acquire natural immunity by near-universal contact with 
the virus.
History of Poliomyelitis in Jamaica
Prior to 1954, notifications of polio in Jamaica were rare. It is important to 
note, however, that polio was apparently always present. Notifications had ranged 
between 0 and 13 each year since 1929, and with only one year (1950) having more than 
10 cases and only one year (1943) having none. There was no pattern to the notifica­
tions, and no tendency to increase up until 1954. Additional evidence that the virus 
was active and indeed quite prevalent in Jamaica has been obtained by the examination 
of sera obtained for various reasons before 1954. Examination of such sera has revealed 
a high percentage of persons with antibodies to all 3 types of poliovirus. Thus, even 
though clinical polio was rare in Jamaica prior to 1954, there is evidence of wide­
spread infection by polioviruses.
During the decade prior to 1954, there was a dramatic rise in the living stand­
ards in Jamaica. Safe water, sanitary conveniences, medical care, and adequate infant 
care were rare during the 1930's and early 1940's, but became available to increasingly 
large percentages of the population during the post-war period. As can be seen in 
Figure I, the Infant Mortality Rate declined steadily during this period, and the Per 
Capita Income rose concomitantly. The indices are thought to mirror the types of changes 
which lead to better hygiene and presumably decreased fecal-oral spread of intestinal 
viruses such as polio.
In 1954 a severe epidemic of 759 reported cases of poliomyelitis with 94 deaths 
occurred throughout the Island. Serological evidence on a small number of the cases 
indicated that Type I polio was the causative agent. The outbreak started in June, 
reached a peak in September, and had nearly ended by the first of January, 1955. The 
first cases were reported from Kingston (where sanitation and living conditions had 
long been superior to those in the rural parishes); however, cases subsequently occurred 
through the rest of the Island. The attack rates showed somewhat higher rates of disease 
in Kingston than in the rural parishes, but it is impossible to say whether this differ­
ence was due to higher natural immunity in the country areas or poorer notifications 
of the disease. The most interesting feature of this epidemic is that polio was ob­
served in all age groups, although of course attack rates were somewhat higher in the 
preschool children than in other age groups. The numbers of cases by age and the age- 
specific attack rates can be seen in Table I. It should be noted (see Figure III) that 
54 percent of the patients reported were in the 0-4 age group.
In 1957, a second epidemic occurred with 395 cases reported, including 11 deaths. 
The pattern of this somewhat smaller epidemic was similar to the 1954 outbreak, except 
that the disease became prevalent late in March, reached its peak in June, and had vir­
tually disappeared by October. Once again the highest attack rates were in Kingston, 
but the disease was reported from all parishes. The age distribution and age-specific 
attack rates once again showed widespread infection of all age groups (see Table I).
Fifty percent of the cases occurred in the 0-4 age group (see Figure III). Type I polio­
virus was isolated from specimens from 9 cases. An attempt was made to modify it with 
an Island-wide campaign to offer inactivated poliomyelitis vaccine to all children in 
the 0-4 age group. Almost 82,000 children received at least one dose of vaccine through 
this program. Interestingly, only 15 cases occurred in this group (giving an attack 
rate of 18 per 100,000) whereas 166 cases occurred in the remaining 144,000 unprotected 
children (giving an attack rate of 125 per 100,000). Immunizations were routinely 
offered only to the 0-4 age group, and may have had the effect of lowering the attack 
rate in that group.
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In 1960, a third epidemic occurred with 132 cases and 9 deaths. Type I polio­
virus was isolated from patients with clinical illness during this outbreak. The 
pattern was similar to the 1957 epidemic in that it had started in March, peaked in 
June, and was essentially over by November. Once again, the illness had been first 
noted in the Kingston area, but soon spread throughout the Island. Thus it was becoming 
apparent that poliomyelitis was settling into an every-third-year epidemic pattern.
This was perhaps due in part to the failure to routinely immunize the infants born sub­
sequent to the previous epidemic.
Immunization with Oral Poliomyelitis Vaccine 1962-63
In late 1962, the health authorities in Jamaica felt that an epidemic similar 
to the ones which occurred in 1954, 1957 and 1960 might well occur in 1963. Only a 
small number of doses of inactivated vaccine had been given since the 1960 campaign.
It was decided to conduct a mass feeding of oral vaccine to the 0-4 age group in late 
1962 and early 1963. This decision was reinforced by the slow buildup of numbers of re­
ported cases in the inter-epidemic years, suggesting that the population was becoming 
quite susceptible to clinical disease associated with infection by poliovirus. Accord­
ingly, a mass vaccination program was held in which at least 432,000 doses of trivalent 
oral vaccine were administered throughout the Island to the 0-4 age group. Seventy- 
four percent received at least one dose of vaccine, and as many as 57 percent may have 
received two doses. The campaign was thus felt to have had considerable success. This 
feeling was reinforced when in 1963 only 15 cases of poliomyelitis were reported, the 
lowest total since 1956.
During the year and a half between the end of the mass feeding and August 1964, 
essentially no vaccine was given out in Jamaica. In the late summer of 1964, an exten­
sive immunization program was initiated in the rural parishes. By the end of 1964, some 
146,000 doses of trivalent oral poliomyelitis vaccine was given to children in the 0-4 
age group through this program. The vaccine was not offered within the Kingston and 
St. Andrew Corporate area because an extensive immunization campaign with DPT antigen 
had just been completed, and the difficulties in mounting another mass campaign were 
felt to be too great.
The 1964 Epidemic
During the late months of 1964, an outbreak of poliomyelitis occurred which was 
sharply limited to the Kingston-St. Andrew Corporate (KSAC) area, and which was also 
unlike previous epidemics in that it was confined almost entirely to the 0-4 age group.
The epidemic curve is shown in Figure IV. Of the 60 cases and 3 deaths found both 
through notification and by search of hospital -records in the Kingston hospitals, only 
4 were from outside of the KSAC area. The failure of the disease to reach epidemic 
proportions elsewhere on the Island may well be due to the vaccine distributed to pre­
school age children in the rural parishes during the fall of 1964. The age distribu­
tion shown in Table I and Figure III was primarily among preschool age children. Fully 
91 percent of the cases occurred in children less than 5 years old, and 43 of the 60,
(71 percent) were less than 2 years of age. The vast majority of these cases had 
received no immunizations against poliomyelitis.
Discussion
The occurrence of poliomyelitis in epidemic form in infants in Kingston during 
1964 raises some grave issues for the future methods of control of this disease. Prior 
to this outbreak there was no reason to suspect that epidemics would occur unless some 
3 years had elapsed during which newly born children remained unimmunized. Also, success­
ful mass immunization campaigns, it was hoped, might abort such epidemics and by break­
ing up the cycle of naturally occurring infection actually lead to the eradication of 
polio from large populations. The success of the Jamaican mass oral vaccine feeding in 
1962 and 1963 led authorities to feel that there was no great urgency in mounting a 
continuous follow-up program. Rather, the next epidemic, which might not be expected
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until 1965 or 1966, might have been aborted by another mass campaign. There seemed 
little reason to fear that very small numbers of infants, who presumably have little 
close contact with each other, would be sufficient to propagate the virus in epidemic 
proportions. However, the 1964 outbreak makes it apparent that it is not advisable 
to allow even small numbers of susceptibles to be built up through failure to reach 
and continuously immunize newly born children. The fact that poliomeylitis became 
epidemic only in Kingston where no vaccine had been used for some 18 months, while the 
well immunized rural areas were almost completely spared, emphasizes this concept. Thus, 
to eradicate poliomyelitis for any more than a brief period of time, continuous vaccina­
tion of young infants must be carried out.
Prior to the widespread availability of good sanitary conditions, near-universal 
natural infection with wild poliovirus "controlled" the disease in the sense that it 
did not occur in epidemics. It is now apparent that near-universal artifical infection 
of the very young with live-attenuated vaccine must replace the older situation, or 
local epidemics such as that in Kingston in 1964 will occur. The implications of this, 
and the problems it raises for public health practice and administration are obvious, 
and grave.
Summary and Conclusion
Poliomyelitis in Jamaica before the days of good sanitation and hygiene was 
probably a nearly universal infection, but rarely resulted in clinical illness. Sub­
sequent to 1954, epidemics occurred every 3 years, initially affecting all age groups, 
but progressively concentrating on the very young. Efforts to abort such periodic 
epidemics with vaccine have been successful over short periods, but there are indica­
tions that if vaccination is not vigorously pursued on a routine basis and efforts are 
not made to reach the very young children with vaccine, even small numbers of suscep­
tible children may be enough to result in epidemics of severe clinical disease.
Dr. Luck acknowledges the assistance of Dr. 0. F. Warner, Senior Medical Officer 
(Health) KSAC, who was responsible for providing the up-to-date data on the cases, 
Professor Louis Grant, Professor of Microbiology, University of the West Indies, who 
provided laboratory confirmation, and Dr. Michael Lane, an EIS Officer who assisted 
in the preparation of the manuscript.
ADDENDUM: Supplement to Poliomyelitis Surveillance Report No. 285 (Sept. 30, 1964)
Section II, Table 1 - Additional information received indicates that during the 1963 
mass oral poliomyelitis vaccine program in epidemic areas, 2,986,000 doses of Type I 
oral polio vaccine were fed in Metropolitan Philadelphia and 102,000 doses were fed in 
Cumberland and Perry Counties, Pennsylvania. Previous figures were 1,500,000 doses and 
77,000 doses respectively.
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TABLE I
AGE SPECIFIC POLIO ATTACK RATES
1954, 1957, 1960 and 1964
AGE P0PULATI0N*+ 1954 19 57 1960 1964
Cases rate/100,000 Cases rate/100,000 Cases rate/100,000 Cases rate/100,000
0-4 267,891 413 154 190 71 93 35 54 20 83*
5-9 220 ,696 66 29 51 23 10 4.5 5 2.2 10*
10-14 173,923 39 22 37 21 3 1.7 0 0 0*
15-19 144,812 50 34 21 14 2 1.3 0 0 0*
20-24 124,847 92 74 38 30 1 0.8 0 0 0*
25+ 677,645 99 15 58 9 20 2.9 1 0.1 0.5*
1,609,814 759 47.1 395 24.5 134 8.3 60 3.7
*+ Population Based on 1960 Census
* Rates Based Upon Kingston and St. Andrew Corporate - i9 6 0 Population
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RESULTS OF THE SEPTEMBER 1964 
UNITED STATES IMMUNIZATION SURVEY
Oral Poliovaccine 
Inactivated Poliovaccine 
Diphtheria-Pertussis-Tetanus 
Smallpox 
Influenza
Prepared by
Ida L. Sherman, Assistant Chief, Statistics Section, 
and Statistical Assistants,
Sara Wingo, Julia Stone, Judy Williams
in cooperation with
Earle Gerson, Bureau of the Census

The tables in this Supplement present the results of the September 1964 
survey of the immunization status of the population of the United States 
conducted by the Bureau of the Census in cooperation with the Communicable 
Disease Center. Information was obtained on poliovaccine status, both oral 
and inactivated for ages under 50 years, diphtheria-pertussis-tetanus immu­
nization for children under 15 years, smallpox vaccination for all ages, and 
recent receipt of influenza vaccine for ages 15 years and over.
The immunization data were collected by means of a special questionnaire 
included in the schedule for the Current Population Survey, a survey conducted 
monthly by the Bureau of the Census. The survey sample, with coverage in 
each of the 50 States and the District of Columbia, includes approximately 
110,000 persons in 32,000 interviewed households.
Tables of data are presented in the following Sections:
Section A. Tables 1-5.
Section B. Tables 6-9.
Section C. Tables 10-15
Section D. Table 16.
Section E. Tables 17-22
Section F. Tables 23-25
Section G« Tables 26-27
Area Classification
Cross-classification, Inactivated Poliovaccine 
Status by Oral Poliovaccine Status, Ages 1-4, 5-9
of the Census
Tables 1-5
Section A. United States by Age Groups
Table 1. Oral Poliovaccine Status - United States, 1964
Ages Under 50 Years
Age
Population
(thousands) 3
No
1-2
. of Doses
Unknown
0 No. Stat.
Percent with 
specified doses 
3 1-2 0
<1 4 065 with 1 or more: 1314 with 1 or more : 32.3
1 4 008 1 433 805 1 740 4 26 35.8 20.1 43.4
2 4 108 1 920 845 1 317 2 24 46.7 20.6 32.1
3 4 281 2 214 874 1 177 2 14 51.7 20.4 27.5
4 4 193 2 192 791 1 189 3 18 52.3 18.9 28.4
1-4 16 590 7 759 3 315 5 423 11 82 46.8 20.0 32.7
5-9 20 100 11 330 4 046 4 487 14 223 56.4 20.1 22.3
10-14 18 510 10 689 3 605 4 065 22 129 57.7 19.5 22.0
15-19 15 734 7 833 2 898 4 831 15 157 49.8 18.4 30.7
20-29 22 780 8 749 3 882 9 726 28 395 38.4 17.0 42.7
30-39 22 522 9 443 3 984 8 823 17 255 41.9 17.7 39,2
40-49 23 308 8 723 3 427 10 762 23 373 37.4 14.7 46.2
1-49 139 544 64 526 25 157 48 117 130 1614 46.2 18.0 34.5
Table 2, Inactivated Poliovaccine Status - United 
Ages Under 50 Years
States , 1964
No, (Df Injections
Population Unknown
Age (thousands) >4 3 1-2 0 No. Stat . >4 >3 0
<1 4 065 with 1 or■ more: 1256 with 1 or more : 30.9
1 4 008 617 1 179 602 1 573 12 25 15.4 44.8 39.2
2 4 108 1 193 1 163 501 1 214 9 28 29.0 57.4 29.6
3 4 281 1 625 1 259 468 911 2 16 38.0 67.4 21.3
4 4 193 1 907 1 158 357 752 4 15 45.5 73.1 17.9
1-4 16 590 5 342 4 759 1 928 4 450 27 84 32.2 60.9 26.8
5-9 20 100 11 638 4 632 1 247 2 355 32 196 57.9 80.9 11.7
10-14 18 510 10 692 4 603 1 108 1 943 47 117 57.8 82.6 10.5
15-19 15 734 7 992 4 237 979 2 289 78 159 50.8 77.7 14.5
20-29 22 780 7 213 5 294 2 193 7 550 160 370 31.7 54.9 33.1
30-39 22 522 5 143 4 643 2 341 10 012 79 304 22.8 43.5 44.5
40-49 23 308 3 138 3 392 1 765 14 517 92 404 13.5 28.0 62.3
1-49 139 544 51 158 31 560 11 561 43 116 515 1634 36.7 59.3 30.9
Table 3. Diphtheria-Pertussis-Tetanus (DPT) Immunization Status - United States, 1964
Ages Under 15 Years
No. of Injections
Population Unknown
Age (thousands) >4 3 1-2 0 No. Stat. >4 3 0
<1 4 065 with 1 or more: 2566 with 1 or more: 63.1
1 4 008 805 1 965 546 586 83 23 20.1 49.0 14.6
2 4 108 1 506 1 558 439 483 90 32 36.7 37.9 11.8
3 4 281 1 885 1 487 349 472 72 16 44.0 34.7 11.0
4 4 193 2 095 1 313 345 350 75 15 50.0 31.3 8.3
1-4 16 590 6 291 6 323 1 679 1 891 320 86 37.9 38.1 11.4
5-9 20 100 13 202 3 886 1 183 1 114 470 245 65.7 19.3 5.5
10-14 18 510 12 426 3 152 848 1 100 752 232 67.1 17.0 5.9
1-14 55 200 31 919 13 361 3 710 4 105 1542 563 57.8 24.2 7.4
Table 4. Smallpox Vaccination Status - United States, 1964
All Ages
Age
Population
(thousands)
Total
Ever
Vac.
Vaccinated Within Past 12 mo.
Vac.
Stat
Unk.
. Never 
Vac.
Percent
Ever Last Never 
Vac. Yr. Vac.Total 1st Revac.
Prior 
Stat. 
Unk.
<1 4 065 618 - - - - - 15.2 - -
1 4 008 2 090 1 656 1 593 26 37 104 1 814 52.1 41.3 45.3
2 4 108 2 416 718 633 55 30 100 1 592 58.8 17.5 38.8
3 4 281 2 693 420 328 80 12 62 1 526 62.9 9.8 35.6
4 4 193 2 901 497 321 145 31 75 1 217 69.2 11.9 29.0
1-4 16 590 10 100 3 291 2 875 306 110 341 6 149 60.9 19.8 37.1
5-9 20 100 17 823 3 408 1 619 1 610 179 328 1 949 88.7 17.0 9.7
10-14 18 510 17 274 1 630 249 1 281 100 213 1 023 93.3 8.8 5.5
15-19 15 734 14 849 1 217 118 1 043 56 160 725 94.4 7.7 4.6
20-29 22 780 21 226 1 273 75 1 105 93 321 1 233 93.2 5.6 5.4
30-39 22 522 20 846 755 56 641 58 259 1 417 92.6 3.4 6.3
40-49 23 308 21 079 740 33 643 64 345 1 884 90.4 3.2 8.1
50-64 26 833 21 966 697 38 600 59 429 4 438 81.9 2.6 16.5
>65 17 213 12 798 287 12 250 25 295 4 120 74.4 1.7 23.9
>1 183 590 157 961 13 298 5 075 7 479 744 2691 22 938 86.0 7.2 12.5
Table 5. Influenza Vaccine Obtained Within the Past 12 Months - United States, 1964
15 Years and Over by Age and Sex
Age
Group
Population
(thousands)
Number Receiving 
Influenza Vaccine Percent
Total
15-24 27 858 2 980 10.7
25-44 45 299 5 779 12.8
45-64 38 020 6 010 15.8
>65 17 213 2 946 17.1
>15 128 390 17 715 13.8
Males
15-24 13 294 1 432 10.8
25-44 21 606 3 049 14.1
45-64 18 327 2 847 15.5
>65 7 591 1 275 16.8
>15 60 818 8 603 14.1
Females
15-24 14 564 1 548 10.6
25-44 23 693 2 730 11.5
45-64 19 693 3 163 16.1
>65 9 622 1 671 17.4
>15 67 572 9 112 13.5
Tables 6-9
Section B. By Age by Standard Metropolitan Statistical
Area Classification
Table 6. Oral Poliovaccine Status by Standard Metropolitan
Statistical Area Classification - United States, 1964
Age Population Number of Doses Percent with
Group (thousands) 3 0 3 0
Central Cities
1-4 4 872 2 043 1 723 41.9 35.4
5-9 5 584 2 949 1 270 52.8 22.7
10-14 5 229 2 853 1 087 54.6 20.8
15-19 4 705 2 068 1 550 44.0 32.9
20-29 7 505 2 527 3 485 33.7 46.4
30-39 6 862 2 315 3 163 33.7 46.1
40-49 7 453 2 368 3 774 31.8 50.6
1-49 42 210 17 123 16 052 40.6 38.0
Remaining SMSA Areas
1-4 5 791 2 854 1 617 49.3 27.9
5-9 7 134 4 084 1 334 57.2 18.7
10-14 6 403 3 672 1 224 57.3 19.1
15-19 5 237 2 651 1 465 50.6 28.0
20-29 7 571 3 050 2 978 40.3 39.3
30-39 8 185 3 654 2 748 44.6 33.6
40-49 8 211 3 225 3 564 39.3 43.4
1-49 48 532 23 190 14 930 47.8 30.8
Areas Outside SMSA
1-4 5 927 2 860 2 082 48.3 35.1
5-9 7 382 4 297 1 883 58.2 25.5
10-14 6 878 4 164 1 755 60.5 25.5
15-19 5 792 3 113 1 816 53.7 31.4
20-29 7 704 3 173 3 262 41.2 42.3
30-39 7 475 3 472 2 912 46.4 39.0
40-49 7 644 3 130 3 424 40.9 44.8
1-49 48 802 24 209 17 134 49.6 35.1
Table 7. DPT Immunization Status by Standard Metropolitan Statistical Area 
Classification. Percent of Children Under 15 Years of Age with 
Specified Number of DPT Injections - United States, 1964
Age
Group
Central
Cities
Remaining 
SMSA Areas
Areas Outside 
SMSA
3 or More Injections
1-4 74.0 82.4 71.5
5-9 84.2 88.8 81.9
10-14 83.6 87.3 81.7
4 or More Injections
1-4 37.0 41.9 34.8
5-9 66.2 70.7 60.4
10-14 68.6 70.2 63.1
3 Injections
1-4 36.9 40.5 36.7
5-9 18.0 18.1 21.5
10-14 15.0 17.1 18.5
0 Injections
1-4 11.6 6.0 16.5
5-9 5.6 3.0 8.0
10-14 5.6 4.2 7.8
With 1 or More DPT Injections
< 1 65.1 69.4 55.7
Table 8. Smallpox Vaccination Status by Standard Metropolitan Statistical
Area Classification - United States, 1964
Age
Group
Population
(thousands)
Percent of Persons
Total
Ever
Vaccinated
Received 
Vaccination 
Last Year
Vaccination 
Status Unk.
Never
Vaccinated
Central Cities
< 1 1 222 20.4 — _
1-4 4 872 69.4 23.8 1.9 28.8
5-9 5 584 90.9 16.6 1.8 7.3
10-14 5 229 95.4 10.0 1.3 3.3
15-19 4 705 96.4 8.5 0.9 2.8
20-29 7 505 95.0 6.4 1.4 3.6
30-39 6 862 94.3 4.2 1.5 4.2
40-49 7 453 92.7 3.9 1.9 5.4
50-64 9 247 87.4 3.7 2.1 10.5
> 65 6 014 82.2 2.4 2.1 15.7
> 1 57 471 89.6 7.9 1.7 8.7
Remaining SMSA Areas
< 1 1 363 14.7 —
1-4 5 791 68.8 21.2 2.0 29.2
5-9 7 134 92.9 16.1 1.4 5.7
10-14 6 403 96.0 10.3 0.7 3.3
15-19 5 237 97.1 8.9 0.7 2.3
20-29 7 571 95.1 6.3 1.7 3.2
30-39 8 185 95.4 3.6 0.7 3.8
40-49 8 211 94.8 3.6 0.9 4.2
50-64 8 080 88.6 2.7 1.2 10.3
> 65 4 472 84.8 1.5 1.0 14.2
> 1 61 084 91.0 7.9 1.1 7.9
Areas Outside SMSA
< 1 1 480 11.5 _
1-4 5 927 46.1 15.3 2.3 51.6
5-9 7 382 82.9 18.0 1.7 15.4
10-14 6 878 89.3 6.5 1.4 9.3
15-19 5 792 90.3 6.0 1.5 8.2
20-29 7 704 89.5 4.1 1.2 9.3
30-39 7 475 87.8 2.3 1.3 10.9
40-49 7 644 83.5 2.0 1.7 14.8
50-64 9 506 70.8 1.5 1.5 27.7
> 65 6 727 60.3 1.1 1.9 37.8
> 1 65 035 78.2 6.0 1.6 20.2
Table 9. Influenza Vaccine Obtained Within Past 12 Months - United States, 1964
Age
Group
Population
(thousands)
Obtained Vaccine Percent by Sex
Number Percent Male Female
Central Cities
15-21+ 8 700 1 017 11.7 11.4 11.9
25-1+1+ 11+ 191 1 919 13.5 14.7 12.4
1+5-61+ 12 881 2 119 16.5 16.5 16.4
> 65 6 014 996 16.6 17.6 15.8
> 15 41 786 6 051 14.5 14.9 14.1
Remaining SMSA Areas
15-24 9 176 950 10.4 10.5 10.2
25-44 16 235 2 117 13.0 14.8 11.4
45-64 11 873 1 821 15.3 15.0 15.7
> 65 4 472 702 15.7 15.7 15.7
> 15 41 756 5 590 13.4 14.0 12.8
Areas <Outside SMSA
15-24 9 982 1 Oil 10.1 10.4 9.9
25-44 14 873 1 743 11.7 12.8 10.8
45-64 13 266 2 070 15.6 15.2 16.0
> 65 6 727 1 248 18.6 16.8 20.0
> 15 44
003-00 6 072 13.5 13.6 13.5
Tables 10-15
Section C. By Age and Race for the United States
Table 10. Oral Poliovaccine Status - United States, 1964
by Age and Race
Age
Group
Population 
(thousands)
Percent with 
3 doses
Percent with 
zero doses
White Nonwhite White Nonwhite White Nonwhite
1-4 14 014 2 576 47.8 41.0 32.0 36.3
5-9 17 215 2 885 57.4 50.3 22.5 21.1
10-14 15 939 2 571 57.9 56.6 22.4 19.5
15-19 13 760 1 974 49.9 49.2 31.0 28.5
20-29 20 054 2 726 39.1 33.3 42.6 43.5
30-39 19 955 2 567 43.0 33.8 38.4 45.6
40-49 20 945 2 363 37.9 33.0 45.9 48.5
1-49 121 882 17 662 46.8 42.4 34.5 34.6
Table 11. Inactivated Poliovaccine Status - United 
Percent of Persons with Specified Number
by Age and Race
States, 1964 
of IPV Doses
Age
Percent with 
>4
Percent ' 
3
with Percent
0
with
Group White Nonwhite White Nonwhite White Nonwhite
1-4 33.7 23.8 29.7 23.3 25.2 35.6
5-9 60.8 40.7 22.9 23.6 10.3 20.0
10-14 60.4 41.5 24.0 30.2 9.5 16.5
15-19 52.4 39.7 26.9 26.9 13.5 22.0
20-29 33.1 20.9 23.7 20.2 31.7 43.5
30-39 24.1 13.2 21.4 14.6 42.7 58.2
40-49 14.0 8.6 15.1 10.0 61.4 69.7
1-49 38.1 26.9 22.8 21.2 29.9 37.8
Table 12. DPT Status - United States, 1964. Percent of Persons with Specified 
Number of Injections, by Age and Race, Under 15 Years of Age
Race
Age
1-4
Age
5-9
Age
10-14
Total
1-14
Percent with 3 or More
White 79.3 87.9 86.2 84.8
Nonwhite 58.3 68.1 71.2 65.9
Percent with 4 or More
White 40.0 68.8 69.7 60.6
Nonwhite 26.7 46.8 51.2 41.8
Percent with 3
White 39.3 19.0 16.6 24.2
Nonwhite 31.6 21.2 20.0 24.1
Percent with Zero
White 9.3 4.4 5.0 6.1
Nonwhite 22.9 12.3 11.9 15.6
Age Under 1, Percent with One or More
White 65.8
Nonwhite 49.5
Table 13. Smallpox Vaccination by Age by Race - United States, 1964
Total Vaccination Last Year
Race
Age
Group
Total
Ever
Vac.
Vac.
Last
Year 1st Revac.
Prior
Status
Unk.
Vac.
Status
Unk.
Never
Vac.
White <1 14.9 - - - - —
1-4 62.1 19.7 17.3 1.8 0.7 2.1 35.9
5-9 89.9 16.9 7.6 8.4 0.9 0.9 9.2
10-14 93.7 8.7 1.1 7.1 0.5 1.0 5.3
15-19 94.8 7.7 0.7 6.6 0.4 1.0 4.2
20-29 93.8 5.7 0.3 5.0 0.4 1.3 4.9
30-39 93.2 3.3 0.2 2.8 0.3 1.0 5.8
40-49 91.1 3.2 0.1 2.8 0.3 1.4 7.5
50-64 82.9 2.6 0.1 2.3 0.2 1.5 15.5
>65 75.4 1.6 0.1 1.3 0.2 1.7 23.0
Total >1 86.9 7.1 2.6 4.1 0.4 1.3 11.8
Nonwhite <1 16.7 - - - - - -
1-4 54.5 20.4 17.7 2.1 0.5 1.8 43.6
5-9 81.5 17.2 10.8 5.7 0.7 5.8 12.8
10-14 91.3 9.2 3.1 5.5 0.6 2.1 6.7
15-19 91.4 8.0 1.3 6.6 0 . 1 1 . 0 7.5
20-29 88.6 4.6 0.6 3.8 0.3 2.2 9.2
30-39 87.7 4.0 0.3 3.6 0.2 2.5 9.9
C
Di
o3
- 84.3 3.0 0.3 2.6 0 . 1 2.1 13.6
50-64 71.3 2.5 0.3 2.0 0.2 2.4 26.3
>65 62.5 2.6 0 2.6 0 2.0 35.5
Total >1 79.9 8.4 4.2 3.9 0.3 2.5 17.5
Table 14. Influenza Vaccine Obtained in Past 12 Months 
by Age, Race, and Sex - United States, 1964
Males Females
White Nonwhite White Nonwhite
Age 15-24
Population 11 652 1 642 12 772 1 792
% With 10.4 13.7 10.1 14.5
Age 25-44
Population 19 321 2 285 20 880 2 813
% With 13.6 18.2 10.9 16.1
Age 45-64
Population 16 616 1 711 17 812 1 881
% With 15.4 17.0 16.0 16.4
Age >65
Population 6 979 612 8 895 727
% With 17.1 13.1 17.8 11.6
Ages 15 and Over
Population 54 568 6 250 60 359 7 213
% With 13.9 16.2 13.3 15.3
Table 15. Immunization Status in Central Cities of Standard Metropolitan 
Statistical Areas - United States, 1964 - Percent with 
Specified Number of Doses by Race and Age
A. Oral Poliovaccine
Age
Group White Nonwhite
3 doses
1-4 43.7 37.4
5-9 54.1 49.1
10-14 55.5 51.6
15-19 44.5 42.0
20-29 34.9 28.8
30-39 35.2 28.5
40-49 32.4 29.0
1-49 41.5 37.5
B. Diphtheria-Pertussis-Tetanus Injection
Age
Group White Nonwhite
3 or more injections
1-4 78.1 63.4
5-9 88.0 73.6
10-14 85.8 76.3
4 or more injections
1-4 40.1 29.4
5-9 70.5 54.2
10-14 71.9 57.9
3 injections
1-4 38.1 34.0
5-9 17.5 19.5
10-14 14.0 18.3
0 injections
1-4 9.4 17.3
5-9 4.2 9.3
10-14 4.4 9.5
Table 15. con't. —  Immunization Status by Race and Age in Central Cities 
of Standard Metropolitan Statistical Areas - United States, 1964
C. Smallpox Vaccination Status
Race
Age
Group
Total
Ever
Vac.
Total
Vac.
Last
Year
Vaccination Last Year
Prior
Status
1st Revac. Unk.
Vac.
Status
Unk.
Never
Vac.
White <1 18.7 - - - - - -
1-4 70.7 24.2 20.6 2.5 1.0 1.9 27.5
5-9 91.8 16.8 5.8 10.2 0.7 0.9 7.2
10-14 95.8 9.9 0.7 8.7 0.6 1.1 3.1
15-19 96.8 9.0 0.4 8.2 0.4 0.9 2.3
20-29 95.8 6.9 0.4 6.0 0.5 1.2 2.9
30-39 95.3 4.1 0.2 3.8 0.1 1.1 3.7
40-49 93.7 4.2 0.2 3.7 0.3 1.8 4.5
50-64 89.1 3.8 0.2 3.3 0.3 1.8 9.1
>65 83.8 2.2 0.1 2.0 0.1 2.0 14.2
Total >1 90.7 7.8 2.3 5.0 0.4 1.5 7.8
Nonwhite <1 24.8 - - - - - -
1-4 66.3 22.8 19.3 2.8 0.7 1.8 31.9
5-9 88.4 16.1 9.0 6.3 0.8 4.2 7.4
10-14 93.9 10.0 2.3 6.5 1.1 2.0 4.1
15-19 94.8 6.4 0.4 5.8 0.2 0.6 4.7
20-29 91.6 4.6 0.7 3.7 0.3 2.2 6.1
30-39 90.9 4.5 0.4 4.0 0.1 2.9 6.2
40-49 88.4 2.3 0.1 2.1 0.1 2.2 9.5
50-64 78.0 3.1 0.3 2.5 0.3 3.5 18.5
>65 70.1 3.6 0 3.6 0 2.3 27.6
Total >1 85.3 •
CO 3.9 4.1 0.4 2.5 12.2
D. Percent with Influenza Vaccine Obtained in Past 12 Months
Age
Group
Male Female
Whit* Nonwhite White Nonwhite
15-24 10.5 15.2 11.3 14.1
25-44 13.7 18.8 11.3 16.5
45-64 16.4 16.9 16.3 17.1
>65 17.8 16.1 16.2 12.4
>15 14.5 17.2 13.7 15.8
Table 16
Section D. Cross-classification, IPV Status by OPV Status, Ages 1-4, 5-9
Table 16. Number (in thousands) of Children 1-4 and 5-9 with Specified Number of 
Inactivated Poliovaccine Inoculations Classified by Number of 
Oral Poliovaccine Doses - United States, 1964
Number of 
IPV
Inoculations
Number of OPV Doses Unknown Total
Children3 2 1 0 Number Status
Age 1-4
4 or more 2 633 672 332 1 694 9 2 5 342
3 2 175 646 332 1 604 - 2 4 759
2 414 223 133 422 - 4 1 196
1 245 121 78 281 - 7 732
0 2 264 562 213 1 411 - - 4 450
Unk. No. 11 3 - 9 2 2 27
Unk. Status 17 2 65 84
Total 7 759 2 227 1 088 5 423 11 82 16 590
Number of 
IPV
Inoculations
Number of OPV Doses Unknown Total
Children3 2 1 0 Number Status
Age 5-9
4 or more 6 692 1 650 582 2 699 3 12 11 638
3 2 643 774 232 965 4 14 4 632
2 396 181 87 177 - 3 844
1 146 81 55 115 - 6 403
0 1 435 276 115 525 2 2 2 355
Unk. No. 9 3 5 3 5 7 32
Unk. Status 9 5 3 - 179 196
Total 11 330 2 970 1 076 4 487 14 223 20 100
Section E. Detailed Data for Age Group, 1-4 Years
Tables 17-22
Table 17. Percent of Children, 1-4 Years , with Specified Number of OPV
Doses, by Single Years of Life, by Race - United States, 1964
Population Oral Poliovaccine Doses
Age (thousands) 3 2 1 0
White
1 3 416 36.9 12.5 7.1 43.5
2 3 449 47.3 13.5 6.8 32.4
3 3 622 53.0 14.4 6.0 26.6
4 3 527 53.6 13.1 5.7 27.7
Nonwhite
1 592 29.1 15.5 8.3 47.1
2 659 43.7 13.4 9.0 34.0
3 659 44.6 11.8 9.1 34.4
4 666 45.5 14.1 5.9 34.5
Note: In these tables children reported as having received an unknown number of
doses or inoculations are included in the percentages computed for children 
with 1 dose;those reported with status unknown, in percentages computed 
for 0 doses.
CM CO
Table 18. Percent of Children, 1-4 Years, with Specified Number of OPV Doses 
by Single Years of Life, by Major Geographic Divisions -United States, 1964
Age New England States
Number of OPV
3 2 1 0
Middle Atlantic States
Doses
3 2 1 0
1 37.2 18.2 15.0 29.6 37.6 10.2 7.5 44.8
2 52.2 10.3 13.3 24.1 46.4 11.9 6.8 34.9
3 50.2 15.7 12.9 21.3 50.8 10.2 6.5 32.4
4 59.6 15.0 5.8 19.6 50.6 9.3 5.7 34.4
1-4 49.8 15.1 11.6 23.6 46.4 10.4 6.6 36.6
East North 
3 2
Central
Number
1 0
West North
of OPV Doses
3 2
Central 
1 0
1 25.5 13.8 8.5 52.2 25.5 16.5 5.6 52.5
2 30.1 20.9 6.6 42.5 37.4 14.6 6.5 41.4
3 39.0 21.1 6.9 33.1 40.1 15.2 4.1 40.6
4 34.9 19.8 8.0 37.3 36.3 19.3 4.2 40.2
1-4 32.4 18.9 7.5 41.2 35.0 16.5 5.0 43.5
South Atlantic 
3 2 1 0
East South Central 
Number of OPV Doses
3 2 1 0
West
3
South
2
Central 
1 0
1 41.5 16.7 5.3 36.6 54.2 11.3 2.9 31.5 38.7 8.7 7.9 44.7
2 51.3 14.7 5.6 28.5 56.9 8.4 8.4 26.3 61.9 7.5 7.2 23.3
3 55.3 16.4 5.7 22.7 68.5 8.6 2.6 20.2 61.2 12.1 9.1 17.6
4 57.1 14.6 4.5 23.8 62.4 8.2 4.2 25.2 71.5 8.9 4.5 15.2
1-4 51.4 15.6 5.3 27.8 61.2 8.9 4.6 25.3 57.9 9.3 7.1 25.7
Mountain States Pacific States
Number of OPV Doses
3 2 1 0 3 2 1 0
37.7 14.3 8.0 40.0 37.1 9.7 6.3 47.0
62.7 5.7 4.2 27.4 50.8 12.0 8.8 28.4
69.8 9.8 3.3 17.2 54.8 9.7 7.1 28.4
66.5 11.6 1.2 20.8 58.1 8.8 7.6 25.4
59.9 10.2 4.1 25.9 50.9 10.1 7.5 31.5
H CM CO ^
Table 19. Percent of Children, 1-4 Years, with Specified Number of OPV
Doses, by Standard Metropolitan Statistical Area Classification
United States, 1964
Standard Metropolitan Statistical Areas Areas Excluding SMSA's
Age Central Cities Excluding Central Cities
Number of OPV Doses
3 2 1 0 3 2 1 0 3 2 1 0
1 29.0 13.5 8.7 48.7 39.3 15.3 6.3 39.1 38.2 10.2 6.9 44.6
2 41.0 14.7 8.0 36.2 48.4 16.1 7.1 28.4 49.8 9.8 6.5 33.8
3 48.9 14.3 7.1 29.7 52.4 17.7 7.3 22.6 53.1 10.0 5.2 31.6
4 48.8 16.6 5.3 29.3 56.1 13.9 5.9 24.2 51.2 9.8 5.9 33.0
1-4 41.9 14.8 7.2 36.0 49.3 15.8 6.6 28.3 48.3 10.0 6.1 35.7
SMSA Central Cities, by Race 
White Nonwhite
Number of OPV Doses
3 2 1 0 3 2 1 0
31.7 11.3 8.7 48.3 21.1 20.1 8.8 50.0
41.2 14.6 7.7 36.5 40.7 15.0 8.9 35.4
51.8 14.2 6.5 27.5 41.8 14.8 8.5 34.9
50.8 15.3 5.2 28.7 44.0 19.7 5.7 30.6
43.7 13.8 7.0 35.5 37.4 17.3 7.9 37.4
Diphtheria-Pertussis-Tetanus
Table 20. Percent of Children, 1-4 Years, with Specified Number of
DPT Inoculations, by Single Years of Life, by Race
United States, 1964
Population ________ Number of Inoculations
Age (thousands) 4 or more 3 1-2 0
White
1 3 416 21.4 51.4 12.4 14.8
2 3 449 38.4 39.0 10.6 11.9
3 3 622 46.5 35.0 7.8 10.7
4 3 527 52.7 32.3 7.5 7.5
Nonwhite
1 592 12.7 35.3 20.6 31.4
2 659 27.6 32.2 11.4 28.8
3 659 30.2 33.1 11.2 25.5
4 666 35.1 26.1 12.5 26.3
Table 21. Percent of Children, 1-4 Years, with Specified Number of DPT Inoculations, 
by Single Years of Life, by Race, by Standard Metropolitan Statistical Area
Classification - United States, 1964
_______ Standard Metropolitan Statistical Areas Areas Excluding SMSA's
Age Central Cities Excluding Central Cities
Number of DPT Inoculations
4+ 3 1-2 0 4+ 3 1-2 0 4+ 3 1-2 0
1 21.5 46.9 13.3 18.3 22.0 53.5 14.0 10.6 17.0 46.7 13.4 22.8
2 34.3 37.2 11.4 17.1 41.7 40.4 10.0 7.9 33.9 36.3 10.9 19.0
3 43.8 33.8 10.5 11.8 47.1 36.7 7.7 8.5 41.2 33.5 7.1 18.2
4 48.8 30.0 9.8 11.3 54.9 32.7 6.1 6.3 46.0 31.0 9.2 13.9
1-4 37.0 36.9 11.3 14.7 41.9 40.5 9.3 8.3 34.8 36.7 10.1 18.4
SMSA Central Cities, by Race 
White Nonwhite
Number of DPT Inoculations
4+ 3 1-2 0 4+ 3 1-2 0
1 23.4 49.6 11.8 15.1 15.9 38.6 17.9 27.6
2 36.2 38.5 11.1 14.2 29.8 34.0 12.0 24.2
3 48.2 31.9 9.5 10.3 32.7 38.6 13.1 15.6
4 53.5 31.7 7.9 6.8 37.4 26.0 14.3 22.3
1-4 40.1 38.1 10.1 11.7 29.4 34.0 14.3 22.3
Table 22. Percent of Children,1-4 Years, with Specified Number of DPT
Inoculations,by Single Years of Life, by Major Geographic Divisions
United States, 1964
Age New England States Middle Atlantic States
Number of DPT Inoculations
4+ 3 1-2 0 4+ 3 1-2 0
1 19.8 58.1 11.9 10.3 27.1 50.8 10.2 12.0
2 42.9 43.8 4.4 8.9 37.1 42.9 10.2 9.7
3 43.0 41.0 7.2 8.8 47.1 37.1 8.9 6.8
4 56.3 32.5 4.6 6.7 51.0 35.0 6.8 7.2
1-4 40.1 44.0 7.2 8.8
CO•ozt CO•zt 9.0 8.9
East North Central
Number of DPT 
4+ 3 1-2 0
West North 
Inoculations
4+ 3
Central 
1-2 0
1 17.6 50.9 16.2 15.2 18.3 50.3 15.5 15.8
2 32.4 46.6 9.5 11.5 34.0 44.9 10.6 10.6
3 42.6 36.9 9.8 10.7 41.3 40.8 5.4 12.4
4 48.3 33.1 9.9 8.6 46.8 36.0 7.3 10.0
1-4 35.3 41.9 11.3 11.5 35.5 42.9 9.5 12.1
South Atlantic East South Central West South Central
Number of DPT Inoculations
4+ 3 1-2 0 4+ 3 1-2 0 4+ 3 1-2 0
1 19.4 47.6 10.5 22.4 16.0 39.9 16.8 27.3 22.6 38.0 9.4 30.0
2 40.6 27.5 12.1 19.7 31.8 31.4 13.1 23.7 41.9 23.6 7.8 26.7
3 46.2 28.7 7.9 17.2 49.7 26.8 7.0 16.6 44.9 22.6 10.5 22.0
4 51.7 27.7 6.8 13.8 49.0 19.9 10.5 20.6 57.6 20.4 8.9 13.1
1-4 39.8 32.8 9.3 18.2 37.9 28.8 11.5 21.7 41.2 26.4 9.1 23.2
Mountain States
Number of DPT Inoculations
Pacific States
4+ 3 1-2 0 4+ 3 1-2 0
1 15.4 52.6 17.1 14.9 17.5 52.2 18.8 11.6
2 25.0 47.2 11.3 16.5 41.2 32.3 14.5 12.0
3 41.9 34.4 10.7 13.0 39.4 40.7 6.2 13.6
4 35.8 40.5 14.5 9.2 47.8 35.3 8.1 8.8
1-4 30.1 43.6 13.2 13.1 37.4 39.3 11.8 11.5
Tables 23-25
Section F. By Age Groups by Geographic Divisions
Summary Table
Table 23. Percent of Persons with Specified Number of Doses by
Age Group, by Geographic Division - United States, 1964
Age
Group
New
Eng.
Mid.
Atl.
E.N.
Cent.
W.N.
Cent.
So.
Atl.
E.S.
Cent.
w.s.
Cent. Mtn. Pac.
Percent with 3 0PV
1-4 49.8 46.4 32.4 35.0 51.4 61.2 57.9 59.9 50.9
5-9 65.4 54.0 38.6 45.3 60.1 74.8 73.5 75.8 60.4
10-14 64.0 51.6 39.8 46.0 65.8 77.5 74.1 77.3 60.8
15-19 46.2 43.8 34.6 42.5 55.2 65.5 65.6 67.3 55.5
20-29 25.3 33.3 27.2 36.4 44.0 52.1 52.7 59.6 39.9
30-39 26.6 37.4 30.5 33.8 47.3 61.2 59.4 65.2 46.4
40-49 21.1 34.5 27.0 28.6 43.1 53.2 55.3 59.9 40.8
Total
1-49 40.3 41.9 32.5 37.9 51.8 63.5 62.2 66.1 49.7
Percent with 4 or more DPT
1-4 40.1 40.8 35.3 35.5 39.8 37.9 41.2 30.1 37.4
5-9 69.8 61.4 68.9 63.3 65.1 63.4 68.8 55.8 68.5
10-14 73.5 59.9 70.2 67.4 63.9 66.2 66.7 65.1 73.9
Total
1-14 62.6 54.6 59.4 56.5 57.1 57.1 59.6 50.5 60.7
Percent Ever Receiving Smallpox
1-4 61.2 71.6 66.1 63.5 50.1 43.8 38.0 59.1 74.5
5-9 93.6 95.5 88.5 86.7 86.7 80.1 82.6 86.3 90.4
10-14 98.3 97.8 93.3 86.8 94.9 88.3 90.3 92.8 93.2
15-19 97.9 98.4 94.0 86.9 96.7 87.0 92.5 93.8 95.7
20-29 97.1 97.5 91.9 85.3 95.7 87.0 90.6 93.6 93.6
30-39 95.5 97.2 91.4 87.5 93.7 86.3 88.3 92.8 93.5
40-49 94.9 96.3 90.0 83.4 90.0 79.2 87.7 91.0 91.7
50-64 91.4 93.7 80.5 72.7 80.4 63.6 71.5 79.3 83.9
> 65 88.5 89.9 72.7 61.9 70.7 52.3 63.5 72.8 78.0
Total
> 1 91.8 93.6 85.7 79.4 85.2 75.0 78.9 85.3 88.7
Table 24. Percent of Persons by Age Groups with Specified Number of Doses
OPV, DPT, and Smallpox in each Geographic Division - United States, 1964
A. New England
OPV______  __________ DPT_________  Smallpox
Age
Group 3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 49.8 26.3 23.7 40.1 44.0 7.2 7.2 61.2 37.5 17.0
5-9 65.4 26.6 8.1 69.8 18.8 4.6 5.3 93.6 6.0 11.2
10-14 64.0 28.2 7.5 73.5 14.8 5.1 3.7 98.3 1.5 4.4
15-19 46.2 30.9 22.4 - - - - 97.9 1.9 8.8
20-29 25.3 18.4 53.9 - - - - 97.1 1.7 6.2
30-39 26.6 19.6 53.0 - - - - 95.5 4.1 1.6
40-49 21.1 17.4 60.0 - - - ♦ 94.9 4.2 3.1
50-64 - - - - - - - 91.4 7.6 1.9
> 65 - - - - - - 88.5 10.7 1.7
Total Total Total
1-49 40.3 23.1 35.7 1-14 62.6 24.6 5.5 5.3 > 1 91.8 7.4 5.6
with 1 or more: with 1 or more: ever vaccinated:
<1 yr. 46.6 71.4 13.5
B. Middle Atlantic
OPV______  __________ DPT_________  Smallpox
Age
Group 3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 46.4 16.9 36.4 40.8 41.3 8.8 6.9 71.6 26.6 23.3
5-9 54.0 20.4 25.2 61.4 23.6 5.5 6.8 95.5 3.8 12.0
10-14 51.6 21.6 26.2 59.9 21.4 6.8 6.8 97.8 1.6 6.5
15-19 43.8 17.3 37.8 - - - - 98.4 1.1 6.3
20-29 33.3 11.2 54.2 - - - - 97.5 1.8 5.9
30-39 37.4 12.8 48.7 - - - - 97.2 2.1 4.0
40-49 34.5 8.1 55.5 - - - - 96.3 2.4 2.8
50-64 — - - - - - 93.7 5.4 3.2
> 65 - - - - - - - 89.9 9.3 1.7
Total Total Total
1-49 41.9 14.7 42.3 1-14 54.6 28.3 6.9 6.9 > 1 93.6 5.4 6.5
with 1 or more: with 1 or more: ever vaccinated
<1 yr. 31.1 66.9 19.1
Table 24. con't. —  Percent of Persons by Age Groups with Specified Number of Doses
OPV, DPT, and Smallpox in each Geographic Division - United States, 1964
C. East North Central
Age
Group
OPV DPT Smallpox
3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 32.4 26.3 40.6 35.3 41.9 11.3 9.9 66.1 31.7 20.0
5-9 38.6 28.1 29.7 68.9 16.2 6.0 3.5 88.5 7.6 17.0
10-14 39.8 27.9 31.1 70.2 16.5 4.6 4.4 93.3 5.0 9.2
15-19 34.6 25.3 38.7 - - - - 94.0 4.8 6.9
20-29 27.2 21.3 49.4 - - - - 91.9 6.4 5.5
30-39 30.5 23.1 44.9 - - - - 91.4 7.4 2.6
40-49 27.0 19.4 51.6 - - - - 90.0 8.4 2.8
50-64 - - - - - - - 80.5 18.0 1.7
> 65 - - 72.7 25.3 2.2
Total Total Total
1-49 32.5 24.2 41.4 1-14 59.4 23.9 7.1 5.7 > 1 85.7 12.4 7.1
with 1 or more: with 1 or more: ever vaccinated:
<1 yr. 25.0 63.3 17.3
D. West North Central
Age
Group
OPV DPT Smallpox
3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 35.0 21.3 42.7 35.5 42.9 9.5 10.9 63.5 33.6 18.9
5-9 45.3 21.6 31.9 63.3 22.4 7.9 3.9 86.7 11.8 18.0
10-14 46.0 19.8 32.1 67.4 20.4 3.8 5.0 86.8 10.9 7.0
15-19 42.5 15.6 39.2 - - - - 86.9 9.9 8.1
20-29 36.4 13.9 47.0 - - - - 85.3 12.2 4.3
30-39 33.8 20.6 43.2 - - - - 87.5 10.1 2.5
40-49 28.6 15.3 53.3 - - - - 83.4 14.0 1.9
50-64 - - - - - - - 72.7 23.8 1.1
> 65 - - 61.9 34.5 1.4
Total Total Total
1-49 37.9 18.3 41.6 1-14 56.5 27.7 7.0 6.3 > 1 79.4 17.9 6.5
with 1 or more: with 1 or more: ever vaccinated:
<1 yr. 24.1 63.1 16.3
Table 24. con't. —  Percent of Persons by Age Groups with Specified Number of Doses
OPV, DPT, and Smallpox in each Geographic Division - United States, 1964
E. South Atlantic
OPV______  DPT_________  Smallpox
Age
Group 3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 51.4 20.8 27.4 39.8 32.8 9.3 15.2 50.1 48.2 18.2
5-9 60.1 21.0 18.5 65.1 19.2 5.8 5.5 86.7 12.5 15.9
10-14 65.8 18.8 14.9 63.9 18.1 3.7 6.9 94.9 4.3 6.6
15-19 55.2 17.7 26.6 - - - - 96.7 2.8 6.2
20-29 44.0 21.2 33.5 - - - - 95.7 3.7 4.5
30-39 47.3 19.3 32.6 - - - - 93.7 5.6 2.5
40-49 43.1 15.5 40.6 - - - - 90.0 9.2 3.1
50-64 - - - - - - - 80.4 18.5 2.3
> 65 - - - - 70.7 28.3 1.5
Total Total Total
1-49 51.8 19.2 28.3 1-14 57.1 22.9 6.1 8.9 > 1 85.2 13.9 6.4
with 1 or more: with 1 or more: ever vaccinated:
< 1 yr. 36.7 58.5 7.7
F. East South Central
Age
Group
OPV DPT Smallpox
3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 61.2 13.6 24.9 37.9 28.8 11.3 19.1 43.8 54.0 12.1
5-9 74.8 10.1 14.4 63.4 18.4 4.2 9.9 80.1 18.4 15.4
10-14 77.5 8.7 13.7 66.2 15.4 2.6 9.7 88.3 11.2 6.5
15-19 65.5 10.9 23.5 - - - - 87.0 12.4 4.2
20-29 52.1 12.5 33.6 - - - - 87.0 11.6 4.4
30-39 61.2 9.7 28.4 - - - - 86.3 12.3 2.0
40-49 53.2 10.6 35.1 - - - - 79.2 19.3 2.2
50-64 - - - - - - - 63.6 34.0 1.4
> 65 - “ - 52.3 45.5 0.6
Total Total Total
1-49 63.5 10.8 25.0 1-14 57.1 20.3 5.7 12.5 > 1 75.0 23.4 5.3
with 1 or more: with 1 or more: ever vaccinated:
<1 yr. 33.6 54.2 6.1
Table 24. con't. —  Percent of Persons by Age Groups with Specified Number of Doses
OPV, DPT, and Smallpox in each Geographic Division - United States, 1964
G. West South Central
OPV_______  __________ DPT_________  Smallpox
Age
Group 3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 57.9 16.4 24.9 41.2 26.4 9.0 19.6 38.0 59.8 14.9
5-9 73.5 13.3 12.9 68.8 13.0 6.3 8.9 82.6 16.7 22.3
10-14 74.1 12.7 12.8 66.7 13.9 4.2 8.8 90.3 9.1 9.8
15-19 65.6 15.1 18.2 - - - - 92.5 6.8 9.1
20-29 52.7 20.3 25.6 - - - - 90.6 7.8 5.5
30-39 59.4 19.8 19.9 - - - - 88.3 10.7 4.4
40-49 55.3 16.8 26.3 - - - - 87.7 11.0 4.4
50-64 - - - - - - - 71.5 26.9 2.3
> 65 - - - - - 63.5 34.7 1.1
Total Total Total
1-49 62.2 16.5 20.3 1-14 59.6 17.5 6.4 12.2 > 1 78.9 19.8 7.7
with 1 or more: with 1 or more: ever vaccinated
<1 yr. 29.0 51.3 5.6
H. Mountain
OPV______  __________ DPT_________  Smallpox
Age
Group 3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 59.9 14.1 25.7 30.1 43.6 13.2 13.0 59.1 38.2 22.2
5-9 75.8 9.8 14.0 55.8 30.8 6.0 6.1 86.3 12.2 23.2
10-14 77.3 8.4 13.8 65.1 21.4 5.2 4.7 92.8 6.1 18.5
15-19 67.3 12.9 18.8 - - - - 93.8 4.5 13.3
20-29 59.6 13.1 26.2 - - - - 93.6 5.2 7.4
30-39 65.2 11.4 23.3 - - - - 92.8 6.9 4.1
40-49 59.9 12.0 26.5 - - - - 91.0 7.5 3.7
50-64 - - - - - - - 79.3 18.0 5.1
> 65 - - - - - 72.8 23.4 1.0
Total Total Total
1-49 66.1 11.7 21.4 1-14 50.5 31.9 8.0 7.9 > 1 85.3 13.0 11.2
with 1 or more: with 1 or more: ever vaccinated
<1 yr. 33.1 62.1 15.9
Table 24. con't. —  Percent of Persons by Age Groups with Specified Number of Doses
OPV, DPT, and Smallpox in each Geographic Division - United States, 1964
I. Pacific
Age
Group
OPV DPT Smallpox
3 1-2 0 > 4 3 1-2 0 Ever Never
Last
Year
1-4 50.9 17.5 31.0 37.4 39.3 11.6 7.2 74.5 24.0 25.7
5-9 60.4 14.6 24.4 68.5 18.2 6.3 3.7 90.4 8.2 21.9
10-14 60.8 14.3 23.9 73.9 11.3 4.3 3.8 93.2 5.2 14.8
15-19 55.5 13.5 30.0 - - - - 95.7 3.5 11.4
20-29 39.9 16.5 40.8 - - - - 93.6 4.2 7.0
30-39 46.4 16.4 35.8 - - - - 93.5 4.4 5.6
40-49 40.8 15.8 41.7 - - - - 91.7 6.5 4.8
50-64 - - - - - - 83.9 14.3 4.9
> 65 - - - - - 78.0 20.2 2.4
Total Total Total
1-49 49.7 15.6 33.2 1-14 60.7 22.5 7.3 4.8 > 1 88.7 9.6 10.5
<1 yr. with 1 or more: with 1 or1 more; ever vaccinated:
40.8 74.1 28.2
Table 25. Percent of Persons Over 15 Years of Age Receiving Influenza
Vaccine in Past 12 Months by Geographic: Division and Age Groups
United States, 1964
Age New Mid. E.N. W.N. Sc>• E.S. w.s.
Group Eng. Atl. Cent. Cent. Atl. Cent. Cent. Mtn. Pac.
15-24 9.5 10.2 10.5 8.4 14 .0 7.9 11.1 9.5 11.6
25-44 12.2 11.9 12.3 9.0 15 .6 12.0 15.4 13.0 12.7
45-64 14.3 14.6 16.2 14.4 1£1.7 12.7 17.0 16.6 16.3
> 65 11.6 15.0 17.8 17.4 16'.1 14.7 23.7 21.0 19.1
> 15 12.2 12.8 13.8 11.8 16..2 11.6 16.0 13.9 14.2
Tables 26-27
Section G. Standard Errors of the Estimated Percentages 
Computed by the Bureau of the Census
The standard errors presented in Tables 26 and 27 provide an indication 
of the order of magnitude of the standard errors rather than precise values 
for any specific item. In order to derive standard errors that would be appli­
cable to the wide variety of items and could be prepared at moderate cost, a 
number of approximations were required.
Table 26. Standard Error of the Estimated Percentage
(A) Of Persons who Received Oral Poliovaccine 
(68 Chances out of 100)
Estimated Base of Percentage (OOO)
Percentage 500 1,000 2,500 5,000 10,000 25,000 50,000 100,000
2 or 98 1.1 .8 .5 .3 .2 .2 .1 .1
5 or 95 1.7 1.2 .8 .5 .4 .2 .2 .1
10 or 90 2.3 1.6 1.0 .7 .5 .3 .2 .2
25 or 75 3.3 2.4 1.5 1.1 .7 .5 .3 .2
50 3.9 2.7 1.7 1.2 .9 .5 .4 .3
(B) Of Persons who Received Inactivated Poliovaccine; and 
who Received DPT Immunizations
of Persons
(68 Chances out of 100)
Estimated Base of Percentage (000)
Percentage 500 1,000 2,500 5,000 10,000 25,000 50,000 100,000
2 or 98 1.4 1.0 .6 .4 .3 .2 .1 .1
5 or 95 2.1 1.5 1.0 .7 .5 .3 .2 .2
10 or 90 3.0 2.1 1.3 .9 .7 .4 .3 .2
25 or 75 4.3 3.0 1.9 1.4 1.0 .6 .4 .3
50 4.9 3.5 2.2 1.6 1.1 .7 .5 .3
(C) Of Persons who Received both Oral and Inactivated Poliovaccine
(68 Chances out of 100)
Estimated Base of Percentage (000)
Percentage 250 500 1,000 2,500 5,000 10 ,000 25,000
2 or 98 1.7 1.2 .9 .6 .4 .3 .2
5 or 95 2.7 1.9 1.4 .9 .6 .4 .3
10 or 90 3.7 2.6 1.9 1.2 .8 .6 .4
25 or 75 5.4 3.8 2.7 1.7 1.2 .9 .5
50 6.2 4.4 3.1 2.0 1.4 1.0 .6
Table 27. Standard Error of Level of Estimates of the Number of Persons
Immunized by Type of Immunization
(68 Chances out of 100)
Level of 
Estimate 
(000)
Standard Error (000)
Oral
Poliovaccine
Inactivated 
Poliovaccine; 
DPT
Inactivated 
Poliovaccine 
and OPV
Smallpox 
Vaccination; 
Influenza 
Vaccine
250 27 35 31 29
500 39 49 44 40
1 000 54 69 61 57
2 500 85 109 92 90
5 000 120 152 120 126
10 000 165 210 140 175
25 000 245 305 260
50 000 305 360 330
Illustrations for Use of the Tables of Standard Errors 
(All numbers in thousands)
Table 1 shows that 46.8 percent (7,759/16,590) of children in the age group 
1-4 had received 3 doses of OPV. Using Table 26 (A), the standard error of 46.8 
percent, based on 16,590 children is found by taking 50 percent (in the first column) 
as approximately equal to 46.8 percent and interpolating between the standard errors,
0.9 and 0.5, given in the body of the table under bases of 10,000 and 25,000 respectively. 
Taking the interpolated value as 0.7 of a percentage point, the chances are 68 out of 
100 that a complete census would have shown a result between 46.1 and 47.5 percent of 
children age 1-4 with three doses of oral poliovaccine; and 95 chances out of 100 that 
a census result would have been between 45.4 and 48.2 percent.
The standard error of the number of 1-4 year old children, 7,759, who had 
received 3 doses of oral poliovaccine can be estimated from Table 27. Referring to 
this table, the number 7,759 falls between 5,000 and 10,000 in the column "Level of 
Estimate" so that the standard error of the estimate (second column, Oral Polio­
vaccine) lies between 165 and 120. By linear interpolation, the standard error of the 
7,759 children in the 1-4 year age group who were reported to have 3 doses of OPV is 
145 (thousand). The chances are 68 out of 100 that a complete census would have 
differed by less than or more than 145 thousands; and 95 out of 100 that the differ­
ence would have been plus or minus 290 thousands.
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